Propionic Acid

Propionic Acid

SCHEMBL4133739

CCC(=O)O.O=C1N=C(Nc2ccc([Na])cc2)SC1=Cc1cc2ccccc2cc1OCc1ccccc1

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTP4A3 O75365 3/20 0.47
CISD1 Q9NZ45 1/20 0.39
PTPN1 P18031 4/20 0.38
CTSV O60911 1/20 0.37
CTSL P07711 1/20 0.37
MEN1 O00255 6/20 0.37
KMT2A Q03164 6/20 0.37
ALDH1A1 P00352 2/20 0.37
POLB P06746 2/20 0.37
KDM4E B2RXH2 1/20 0.37
TTR P02766 1/20 0.37
BLM P54132 1/20 0.37
PLA2G1B P04054 1/20 0.37
HTT P42858 1/20 0.37
ATG4B Q9Y4P1 1/20 0.37
TDP1 Q9NUW8 1/20 0.36
MAPK1 P28482 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
EGFR P00533 1/20 0.35
ERBB2 P04626 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Propionic Acid SCHEMBL4138142 0.95 PTP4A3 (0.43) PTP4A3CISD1PTPN1MEN1KMT2A
Acetic Acid SCHEMBL4125639 0.95 PTP4A3 (0.48) PTP4A3CISD1PTPN1CTSVCTSL
Acetic Acid SCHEMBL4125635 0.95 PTP4A3 (0.48) PTP4A3CISD1PTPN1CTSVCTSL
Propionic Acid SCHEMBL4128569 0.94 PTP4A3 (0.42) PTP4A3CISD1MEN1KMT2AALDH1A1
Butyric Acid SCHEMBL4635070 0.94 PTP4A3 (0.45) PTP4A3CISD1PTPN1CTSVCTSL
SCHEMBL4635271 0.94 PTP4A3 (0.52) PTP4A3CISD1PTPN1MEN1KMT2A
Acetic Acid SCHEMBL4129247 0.90 PTP4A3 (0.44) PTP4A3CISD1PTPN1MEN1KMT2A
Acetic Acid SCHEMBL4129246 0.90 PTP4A3 (0.44) PTP4A3CISD1PTPN1MEN1KMT2A
Propionic Acid SCHEMBL4635089 0.90 ALOX5 (0.40) PTP4A3MEN1KMT2AALDH1A1POLB
Acetic Acid SCHEMBL4132602 0.89 PTP4A3 (0.43) PTP4A3CISD1MEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090088432-A1 Thiazolinones and Oxazolinones and their Use as Ptp1b Inhibitors TORRENT PHARMACEUTICALS LIMITED (IN) 2009-04-02 US claimed
CN-101268060-A Thiazolinone and oxazolinone compounds and application thereof as PTP1B inhibitor TORRENT PHARMACEUTICALS LTD (IN) 2008-09-17 CN claimed
CN-101268060-A Thiazolinone and oxazolinone compounds and application thereof as PTP1B inhibitor TORRENT PHARMACEUTICALS LTD (IN) 2008-09-17 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090088432-A1 Thiazolinones and Oxazolinones and their Use as Ptp1b Inhibitors PTPRF, PTPA, PTPRJ PTP4A3 26/4885CISD1 3041/4885PTPN1 7/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.